Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2018 Oct 6.

Published in final edited form as: Ophthalmology. 2017 Aug 18;125(2):203–209. doi: 10.1016/j.ophtha.2017.07.018

Table 1.

Clinico-pathologic features of uveal melanoma patients without (Group A) and with metastasis (Group B).

		Group A (n=20)	Group B (n=20)	P-value
Age^# (years)		58.5 (15.5)	57.4 (14.3)	0.809
Largest basal diameter^# (mm)		14.28 (4.37)	18.14 (3.93)	0.006
Tumor thickness^# (mm)		6.41 (2.71)	10.65 (8.02)	0.005
TNM Stage	1	5 (25%)	0 (0%)	0.001
	2	2 (10%)	5 (25%)
	3	10 (50%)	3 (15%)
	4	3 (15%)	12 (60%)
Nuclear BAP1 stain	Low	5 (25%)	12 (60%)	0.025^*
Nuclear BAP1 stain	High	15 (75%)	8 (40%)	0.025^*
Cytoplasmic BAP1 stain	Low	1 (5%)	6 (30%)	0.092
Cytoplasmic BAP1 stain	High	19 (95%)	14 (70%)	0.092
BM rupture		7 (35%)	11 (55%)	0.204^*
Vortex vein invasion		0 (0%)	1 (5%)	1.000
Sclera invasion		13 (65%)	18 (90%)	0.127
Extrascleral extension		0 (0%)	3 (15%)	0.231
GEP class	1	8/10 (80%)	2/7 (29%)	0.058
GEP class	2	2/10 (20%)	5/7 (71%)	0.058

^#

Mean (standard deviation)

^*

Chi-square test